Oral immunotherapy for peanut allergy increases risk

There is significant uncertainty over the experimental treatment's long-term safety and efficacy, say experts

Oral immunotherapy for peanut allergy greatly increases the risk of life-threatening anaphylactic reactions rather than preventing them as intended, a review of trials has found.